MCM3AP and prostate carcinoma: Kaplan–Meier survival analysis of TCGA data has shown that over-expression of MCM3AP-AS1 is associated with shorter disease-free survival of patients, indicating that the abnormal expression of MCM3AP-AS1 can participate in the progression of prostate cancer [19].